Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform
Description
Drug repurposing is an important strategy in COVID-19 treatment, but many clinically approved compounds have not been extensively studied in the context of embryogenesis, thus limiting their administration during pregnancy. Here we used the zebrafish
